Clinical utility and technical pitfalls of the serum free light chain (FLC) assay for monitoring of monoclonal light-chain diseases

被引:0
|
作者
Tate, J. R.
Mollee, P.
Carter, A.
Gill, D.
机构
[1] Herston Hosp, Brisbane, Qld, Australia
[2] Princess Alexandra Hosp, Brisbane, Qld, Australia
关键词
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
E44
引用
收藏
页码:A178 / A178
页数:1
相关论文
共 50 条
  • [1] Serum free light chain assay for diagnosis and monitoring of monoclonal light-chain diseases - Analytical and clinical correlations
    Tate, J. R.
    Bazeley, S.
    Sykes, S.
    Mollee, P.
    [J]. CLINICAL CHEMISTRY, 2008, 54 (06) : A123 - A124
  • [2] Analytical performance of serum free light-chain assay during monitoring of patients with monoclonal light-chain diseases
    Tate, Jillian R.
    Mollee, Peter
    Dimeski, Goce
    Carter, Andrew C.
    Gill, Devinder
    [J]. CLINICA CHIMICA ACTA, 2007, 376 (1-2) : 30 - 36
  • [3] Serum-free light-chain assay: clinical utility and limitations
    Bhole, Malini V.
    Sadler, Ross
    Ramasamy, Karthik
    [J]. ANNALS OF CLINICAL BIOCHEMISTRY, 2014, 51 (05) : 528 - 542
  • [4] Clinical Utility of The Serum Free Light Chain Assay in Primary Care
    Lodwick, C.
    Pratt, G.
    Drayson, M.
    Lester, W.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2019, 185 : 15 - 15
  • [5] Serum free light-chain assay for the detection and monitoring of multiple myeloma and related conditions
    Tosi, Patrizia
    Tomassetti, Simona
    Merli, Anna
    Polli, Valentina
    [J]. THERAPEUTIC ADVANCES IN HEMATOLOGY, 2013, 4 (01) : 37 - 41
  • [6] N Latex FLC serum free light-chain assays in patients with renal impairment
    Jacobs, Joannes F. M.
    Hoedemakers, Rein M. J.
    Teunissen, Elisa
    te Velthuis, Henk
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2014, 52 (06) : 853 - 859
  • [7] Serum Free Light Chain Assay in Monoclonal Gammopathic Manifestations
    Lee, Won S.
    Singh, Gurmukh
    [J]. LABORATORY MEDICINE, 2019, 50 (04) : 381 - 389
  • [8] Clinical presentation and prognosis in patients with light-chain amyloidosis with an ultra-high level of serum free light-chain
    苗会蕾
    [J]. China Medical Abstracts (Internal Medicine), 2021, (03) : 186 - 186
  • [9] Utility of the Serum Free Light Chain Assay in the Diagnosis of Light Chain Amyloidosis in Patients With Heart Failure
    Chang, Ian C.
    Dispenzieri, Angela
    Scott, Christopher G.
    Lin, Grace
    Jaffe, Allan S.
    Klarich, Kyle W.
    Grogan, Martha
    [J]. MAYO CLINIC PROCEEDINGS, 2019, 94 (03) : 447 - 454
  • [10] Falsely low serum free light chain concentration in patients with monoclonal light chain diseases.
    Mollee, P
    Tate, J
    Dimeski, G
    Gill, D
    [J]. BLOOD, 2005, 106 (11) : 351B - 351B